Evercore ISI Issues Pessimistic Forecast for Healthpeak Properties (NYSE:DOC) Stock Price

Healthpeak Properties (NYSE:DOCGet Free Report) had its price target reduced by equities researchers at Evercore ISI from $21.00 to $19.00 in a report issued on Wednesday,Benzinga reports. The firm presently has an “outperform” rating on the real estate investment trust’s stock. Evercore ISI’s target price would indicate a potential upside of 13.84% from the stock’s previous close.

Several other equities research analysts have also issued reports on DOC. Robert W. Baird dropped their price objective on shares of Healthpeak Properties from $21.00 to $20.00 and set an “outperform” rating for the company in a research report on Wednesday, November 12th. Wells Fargo & Company reissued a “positive” rating on shares of Healthpeak Properties in a research report on Tuesday. Jefferies Financial Group downgraded Healthpeak Properties from a “buy” rating to a “hold” rating and decreased their target price for the stock from $21.00 to $17.00 in a research report on Monday, December 15th. The Goldman Sachs Group assumed coverage on Healthpeak Properties in a research report on Friday, January 9th. They set a “neutral” rating and a $17.00 price target on the stock. Finally, Cantor Fitzgerald set a $17.00 price target on Healthpeak Properties in a report on Monday, January 5th. Six research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $19.42.

View Our Latest Stock Analysis on Healthpeak Properties

Healthpeak Properties Stock Performance

Shares of NYSE:DOC opened at $16.69 on Wednesday. The firm has a market capitalization of $11.60 billion, a PE ratio of 166.92, a P/E/G ratio of 4.49 and a beta of 1.12. Healthpeak Properties has a 12 month low of $15.71 and a 12 month high of $21.28. The company has a debt-to-equity ratio of 1.21, a current ratio of 2.82 and a quick ratio of 1.22. The business has a 50-day moving average of $16.89 and a two-hundred day moving average of $17.61.

Healthpeak Properties (NYSE:DOCGet Free Report) last issued its earnings results on Monday, February 2nd. The real estate investment trust reported $0.47 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.45 by $0.02. Healthpeak Properties had a return on equity of 0.84% and a net margin of 2.52%.The business had revenue of $719.40 million during the quarter, compared to analysts’ expectations of $685.14 million. During the same quarter in the previous year, the business earned $0.46 EPS. The company’s revenue for the quarter was up 3.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. As a group, research analysts forecast that Healthpeak Properties will post 1.86 earnings per share for the current year.

Institutional Trading of Healthpeak Properties

A number of hedge funds have recently made changes to their positions in DOC. Fifth Third Wealth Advisors LLC boosted its stake in Healthpeak Properties by 2.4% during the 2nd quarter. Fifth Third Wealth Advisors LLC now owns 22,811 shares of the real estate investment trust’s stock valued at $399,000 after acquiring an additional 543 shares during the last quarter. CoreCap Advisors LLC raised its stake in shares of Healthpeak Properties by 22.4% in the 3rd quarter. CoreCap Advisors LLC now owns 3,352 shares of the real estate investment trust’s stock valued at $64,000 after purchasing an additional 613 shares in the last quarter. Fiduciary Trust Co lifted its position in shares of Healthpeak Properties by 4.9% during the third quarter. Fiduciary Trust Co now owns 13,807 shares of the real estate investment trust’s stock worth $264,000 after purchasing an additional 644 shares during the last quarter. Patton Fund Management Inc. grew its stake in Healthpeak Properties by 5.2% in the fourth quarter. Patton Fund Management Inc. now owns 13,002 shares of the real estate investment trust’s stock worth $209,000 after purchasing an additional 648 shares in the last quarter. Finally, Arjuna Capital increased its holdings in Healthpeak Properties by 4.8% in the third quarter. Arjuna Capital now owns 14,768 shares of the real estate investment trust’s stock valued at $283,000 after buying an additional 679 shares during the last quarter. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Company Profile

(Get Free Report)

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

Featured Stories

Analyst Recommendations for Healthpeak Properties (NYSE:DOC)

Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.